Lijun Wang

CoJourney

BIOGRAPHY

Lijun Wang is the Founder and CEO of CoJourney Inc., a specialised CDMO advancing cell and gene therapy programmes across plasmid DNA, viral vectors (AAV/LV), exosomes, and RNA-based therapeutics. Her career spans over 20 years in gene therapy development and bioprocessing.

Lijun brings deep expertise in CMC development and scalable manufacturing, including development of CoJourney's Zero-Chrom plasmid platform, drawing on earlier work at Exegenesis Bio. Her work encompasses IND-enabling studies, Phase II programme advancement, and IIT (Investigator-Initiated Trial) pathway facilitation across the CGT sector.